Literature DB >> 17141074

Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer.

Ki Chang Keum1, Eun Ji Chung, Woong Sub Koom, Jae Ho Cho, Sang Ho Cho, Eun Chang Choi, Chang Geol Lee, Chang Ok Suh, Gwi Eon Kim.   

Abstract

OBJECTIVE: In an attempt to identify molecular markers predictive of occult neck metastases, we investigated whether positive p53 or proliferating cell nuclear antigen (PCNA) immunoreactivities on deparaffinized sections of the primary tumor are correlated to the presence of occult neck node metastases in oral tongue cancer patients with clinically negative cervical nodes (N0). STUDY DESIGN AND
SETTING: Between 1986 and 1997, 37 clinically N0 patients who underwent neck dissection (25 male, 12 female; mean age 54 years) were selected for p53 and PCNA staining.
RESULTS: p53 and PCNA immunoreactivities were detected in 68% and 32%, respectively. There was no correlation between p53 or PCNA and other clinicopathological factors, such as tumor differentiation, tumor type, tumor size, and T-stage. Although tumor differentiation (P=0.03) and tumor size (P=0.03) were significantly correlated with occult neck metastases of oral tongue cancer by univariate analysis, no correlation was found between p53 or PCNA and the presence of occult neck metastasis.
CONCLUSION: p53 and/or PCNA expression are unsuitable as biological markers predictive of lymph node metastases of oral tongue cancer. SIGNIFICANCE: p53- or PCNA-positive status are not a reliable parameter for selection of elective neck dissection in the management of N0 oral tongue cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141074     DOI: 10.1016/j.otohns.2006.02.011

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

Review 1.  Neck dissection: present and future?

Authors:  Alfio Ferlito; Carl E Silver; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

2.  Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy.

Authors:  Su Jung Shim; Jihye Cha; Woong Sub Koom; Gwi Eon Kim; Chang Geol Lee; Eun Chang Choi; Ki Chang Keum
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

3.  Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.

Authors:  Seta A Sarkis; Bashar H Abdullah; Ban A Abdul Majeed; Nazar G Talabani
Journal:  Head Neck Oncol       Date:  2010-06-25

4.  The effects of proliferating cell nuclear antigen and p53 in patients with oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Rui Liu; Kunjun Sun; Yuanda Wang; Yunxian Jiang; Jianyong Kang; Hong Ma
Journal:  Ann Transl Med       Date:  2021-12

5.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.